Nob Hill Therapeutics
Changing the paradigm for high-dose pulmonary drug delivery
Nob Hill Therapeutics is developing new technologies and therapies for lung-related diseases that can’t be effectively treated today. Their new drug inhalation device platform can deliver drugs to the lungs with higher efficiency and deeper into the lower respiratory tract without patient coordination. Nob Hill is also working on drug-device combination products that will serve as point-of-care for the technology.
Latest Nob Hill Therapeutics News
Nob Hill Therapeutics Expands Strategic Advisory Board with Two Distinguished Leaders in Respiratory Drug Development and Pulmonary Medicine
ALBUQUERQUE, N.M., June 18, 2025 /PRNewswire/ — Nob Hill Therapeutics (NHT) is pleased to announce the addition of two prominent experts to its Strategic Advisory Board: Dr. Mark Parry-Billings, a seasoned biotech…
-
Nob Hill Therapeutics Secures Series A Funding to Advance Breakthrough Respiratory Technologies
Nob Hill Therapeutics dry powder nebulizer (DryNeb) Funding Led by Tramway Venture Partners Includes Key Appointments to the Board and Accelerates the Development of High-Dose Lung Delivery Solutions. ALBUQUERQUE, N.M.,…